Study ties estrogen-based menopausal hormone therapy to lower Alzheimer's risk
medicalxpress - Women on regimens of estrogen-only menopausal hormone therapy are at reduced risk of Alzheimer's disease, a study by Stanford Medicine investigators has found. Because estrogen-only therapy is generally prescribed for women without a uterus, most of these…
AI Summary: Observational research linked estrogen‑based menopausal hormone therapy to fewer Alzheimer’s‑related brain changes on imaging, suggesting a potential protective association. Investigators stress that timing, confounding factors and observational design limit causal claims, so randomized trials and careful risk‑benefit assessment remain necessary before changing clinical practice — or anyone swapping kale for HRT on a whim.
There are new blood tests for Alzheimer's. Should I have one?
medicalxpress - Australians have seen a flurry of headlines announcing the arrival of blood tests for Alzheimer's disease.
AI Summary: New blood tests detecting Alzheimer’s biomarkers are reaching clinical availability, promising earlier and less invasive diagnosis. Clinicians and consumers now face decisions about who should be tested, how to interpret results, and what interventions — if any — follow a positive biomarker. The tests shift diagnostic practice while raising ethical and counseling challenges.
Blood-based test can predict risk of developing symptoms of Alzheimer's up to a decade early
medicalxpress - A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged about the extent to which such tests can accurately predict whether a cognitively healthy individual will develop cognitive im…
AI Summary: Researchers validated a blood‑based test that flags individuals at elevated risk of developing Alzheimer’s symptoms up to a decade earlier, showing strong predictive accuracy across cohorts. The finding could enable earlier monitoring and trial enrollment, but raises questions about screening protocols, follow‑up care and the psychological burden of long‑lead risk information.
- Blood biomarkers forecast Alzheimer's risk years ahead (4)
- Genetics and clearance mechanisms shaping Alzheimer's onset (3)
- Sleep, frailty and resilience as non-blood early signals (3)
Blood biomarkers forecast Alzheimer's risk years ahead
Genetics and clearance mechanisms shaping Alzheimer's onset
Sleep, frailty and resilience as non-blood early signals
Dementia care: Re‑envisioning the role of music
medicalxpress - As a certified music therapist, I have observed firsthand the many ways music can bring meaning and beauty into people's lives, even under very difficult circumstances. Much of my clinical work and research has occurred in dementia care. Here, music is of…
AI Summary: Clinicians and care teams are repositioning music from a pleasant diversion to a core therapeutic tool in dementia care. Targeted music interventions are shown to soothe agitation, trigger memories, support communication and daily routines, and empower caregivers. Programs emphasize personalized playlists, staff training and integrating music into clinical care pathways—because sometimes a song works where a pill does not.
- Care priorities, prevention and sensory supports for dementia (4)
- Music and expressive non-drug therapies in dementia care (4)
Care priorities, prevention and sensory supports for dementia
Music and expressive non-drug therapies in dementia care
New Tool That Tracks How the Brain Removes Waste Could Offer Clues About Alzheimer’s
discovermagazine - Learn why understanding how the brain clears its waste could help researchers combat neurodegenerative diseases and age-related cognitive decline.
AI Summary: Researchers unveiled an imaging tool that tracks how the brain removes metabolic waste, mapping preferred drainage routes and pinpointing breakdowns associated with Alzheimer’s pathology. The technique could flag early clearance failure years before symptoms, offering potential biomarkers and therapeutic targets—because sometimes the answer to dementia is less about neurons and more about the plumbing.
First-Ever Smell Map Is a Breakthrough in Sensory Research, a Step to Help Us Tackle Loss of Smell
discovermagazine - Discover how smell receptors in our noses aren’t randomly arranged but are highly organized, offering new paths toward treating sensory impairment.
AI Summary: Scientists have produced the first high‑resolution olfactory map, charting how scent receptors and neural circuits are organized in the nose. The atlas exposes unexpected patterns in odor encoding, helps explain smell loss, and points to new diagnostic and therapeutic pathways — including potential early markers of Alzheimer’s‑related olfactory damage.
- Hidden nose atlas rewrites smell organization, flags Alzheimer links (4)
- New brain markers and tests for early Alzheimer detection (4)
- All Other Stories